Mike Biologics: Net profit attributable to the parent in the first half of the year decreased by 83.12% year-on-year.

Jin10 reported on July 30 that Mike Biotech announced that the company’s operating revenue for the first half of the year was 1.075 billion yuan (RMB), a year-on-year decrease of 15.94%; the net profit attributable to the parent company for the first half of the year was 34.0425 million yuan, a year-on-year decrease of 83.12%; the net cash flow from operating activities was 162 million yuan, a year-on-year decrease of 23.93%.